# EDGAR Filing Document

**Accession Number:** 0002087846
**File Stem:** 0002087846-26-000002
**Filing Date:** 2026-4
**Character Count:** 1697
**Document Hash:** 001ea47fef8f24c249260714393d0137
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002087846-26-000002.hdr.sgml**: 20260427

**ACCESSION NUMBER**: 0002087846-26-000002

**CONFORMED SUBMISSION TYPE**: C-TR

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260427

**DATE AS OF CHANGE**: 20260427

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vertical Longevity Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0002087846

**ORGANIZATION NAME:**
- **EIN:** 334492012
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-TR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-36465
- **FILM NUMBER:** 26900475

**BUSINESS ADDRESS:**
- **STREET 1:** 17 RINCON
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92620
- **BUSINESS PHONE:** 7608558072

**MAIL ADDRESS:**
- **STREET 1:** 17 RINCON
- **CITY:** IRVINE
- **STATE:** CA
- **ZIP:** 92620

### Attached PDF Documents

**Attachment 1:** `Exhibit99.1.pdf`

_No text found in this document._

**Attachment 2:** `Total_Ledger.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Vertical Longevity Pharmaceuticals, Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 03-21-2025

**Physical Address:** 17 RINCON, IRVINE, CA, 92620

**Issuer Website:** vertical-longevity-pharma.com

**Is there a Co-Issuer?:** No

### Signatures

**Issuer:** Vertical Longevity Pharmaceuticals, Inc.

**Signature:** David Scieszka

**Title:** President

---

**Signature:** David Scieszka

**Title:** President

**Date:** 04-27-2026